Associate Manager, Business Analytics - 340B COE- Mettawa, IL

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Job Description

The 340B Drug Pricing program has become a critical issue impacting AbbVie’s business. Originally designed to help safety-net hospitals and clinics give better care to underserved communities, it has now grown exponentially, and deserves a greater level of focus.  Over the past few years, AbbVie has implemented important strategies and policy changes to tackle this growth, but its impact on AbbVie’s portfolio and the complexity of the 340B related issues now require a more dedicated, strategically resourced approach.

Therefore, AbbVie has established a high profile, 340B Center of Excellence (COE), that brings together a team of experts who will utilize analytics and insights to drive strategy, proactively address the growth of 340B and create new solutions to the industrywide abuse within the program.  COE leaders will work with Government Affairs and Legal to develop longer-term solutions and shape reforms while simultaneously collaborating with essential partners, including the Marketing, Finance, Market Access, Public Affairs and other key partners to deliver meaningful business solutions and impact.   

The 340B COE Business Operations Analyst is a member of a group with technical expertise in the business and operations of the 340B program; the group (1) maintains and enforces AbbVie’s 340B program, (2) develops and maintains reporting to track performance, dashboard metrics, 340B entity eligibility compliance), (3) manages 340B duplicate discount scrubbing (4) manages Covered Entity eligibility policy and (5) develops modeling to show the impact of policies, initiatives and government actions.  Develops outlier analyses, new tools, models and platforms to report 340B performance, and 340B forecasts.  Provides mode